EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitScoping Review

Pharmaceutical services in pediatric oncology: A scoping review

Jordânia Ferreira Martins iD, João Pedro Vasconcelos Paolinelli iD, Ricardo Augusto Dos Santos Silva iD, Mariana Linhares Pereira iD

Journal of Oncology Pharmacy Practice · 28.05.2026

DOI: 10.1177/10781552261444975 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Oncology Pharmacy Practice, online erschienen am 28.05.2026. Verfasst von Jordânia Ferreira Martins und 3 weiteren Autor:innen. Beteiligte Einrichtung: Federal University of São João del-Rei, Divinópolis, Brazil. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Although the role of pharmacists in pediatric oncology is well established, scientific production explicitly characterizing the services provided in this field remains limited.

Objective

To map studies on pharmaceutical services in pediatric oncology.

Methods

A scoping review was conducted in accordance with the JBI Manual for Evidence Synthesis and reported following the PRISMA-ScR Checklist. A systematic search was performed in September 2024 across six electronic databases, gray literature, and reference lists of selected studies. Eligible studies included original research and systematic reviews addressing pharmaceutical services in pediatric oncology. Two researchers independently assessed eligibility and extracted data, which were presented descriptively.

Results

Twenty-two articles were included, of which 86.4% (n = 19) were conducted in countries with a very high or high Human Development Index (HDI). Most studies were carried out in hospitals (86.4%; n = 19), with inpatient care being the most frequently addressed setting (54.6%; n = 12). The pharmaceutical services described mainly focused on pharmacotherapy follow-up (46.4%), followed by prescription analysis (18.2%) and compounding of antineoplastic agents (18.2%). In 72.7% (n = 16) of the studies, services were offered in autonomy. Regarding outcomes, 68.2% (n = 15) focused on clinical endpoints. Observational studies predominated (91%; n = 20).

Conclusion

The most frequently identified pharmaceutical services in pediatric oncology were pharmacotherapy follow-up, prescription analysis, and compounding of antineoplastic agents, generally provided autonomously within hospital and outpatient settings. These findings highlight the relevance of pharmacists’ role in this field while underscoring the need for more interventional studies evaluating clinical and economic outcomes.

Schlagwörter

Stichwörter der Autor:innen

medical oncologyneoplasmspediatricspharmaceutical services

Autor:innen und Institutionen

  • Federal University of São João del-Rei, Divinópolis, Brazil.

ORCID-Profile: Jordânia Ferreira Martins, João Pedro Vasconcelos Paolinelli, Ricardo Augusto Dos Santos Silva, Mariana Linhares Pereira

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Zitieren

APA

Martins, J. F., Paolinelli, J. P. V., Silva, R. A. D. S., & Pereira, M. L. (2026). Pharmaceutical services in pediatric oncology: A scoping review. Journal of Oncology Pharmacy Practice. https://doi.org/10.1177/10781552261444975

Vancouver

Martins JF, Paolinelli JPV, Silva RADS, Pereira ML. Pharmaceutical services in pediatric oncology: A scoping review. Journal of Oncology Pharmacy Practice. 2026. doi:10.1177/10781552261444975

BibTeX
@article{Martins2026,
  author = {Martins, Jordânia Ferreira and Paolinelli, João Pedro Vasconcelos and Silva, Ricardo Augusto Dos Santos and Pereira, Mariana Linhares},
  title = {Pharmaceutical services in pediatric oncology: A scoping review},
  journal = {Journal of Oncology Pharmacy Practice},
  year = {2026},
  doi = {10.1177/10781552261444975}
}
Kostenlos starten →